Experience

Jason Savich

    • Eden Capital Invests in Wall Street Prep 


    • Etsy – $1 Billion Convertible Senior Notes Offering 


    • Zoom to Acquire Five9 for $14.7 Billion 


    • NVIDIA – $5 Billion Senior Unsecured Notes Offering 


    • Absolute Software Agrees to Acquire NetMotion Software 


    • Shamrock Capital Investment in Learn on Demand Systems 


    • Metromile to Combine With INSU Acquisition Corp. II, a Special Purpose Acquisition Company 


    • Shamrock Capital Agreement to Acquire Bayard Advertising 


    • Uber On Its $1 Billion Senior Notes Offering 


    • The Underwriters On Livongo Health's $550 Million Convertible Senior Notes 


    • Rapid7 Closes Convertible Offering 


    • DocuSign: $1 Billion Follow-On + Convertible Senior Notes 


    • NVIDIA – $5 Billion Investment Grade Bond Offering 


    • Mitsui Invests In FirstElement Fuel and Partners With Proterra 


    • Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • EnerNOC Sells to Enel Group for More Than $300 Million 


    • Rovi Acquires TiVo for $1.1 Billion 


    • Inotek Pharmaceuticals – $50 Million Follow-On 


    • Web.com to Buy Yodle for $342 Million 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Rovi Corporation Completes $345 Million Convertible Note Offering 


    • Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes 


    • Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes 


    • Jazz Pharmaceuticals plc Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • TriNet – $276 million IPO and $352 million follow-on 


    • Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility 


    • Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • Brocade in $300 Million 4.625 % Senior Notes Offering 


    • Revance Prices $250 Million Convertible Debt Offering 


    • Shake Shack - $250 Million Convertible Senior Notes Offering